BMRN

#761
BioMarin Pharmaceutical Inc. - Common Stock
57.2 9 USD
+8.77%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
57.29
57.29
Intervallo Annuale
49.26
66.28
Variazione giornaliera
+8.77%
Variazione Mensile
+5.60%
Variazione di 6 mesi
+3.23%
Variazione Annuale
-2.02%
Chiusura Precedente
52.6 7
Open
57.2 9
Minimo
57.2 9
High
57.2 9
Volume
194
Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
Conto economico Bilancio Liquidità
Valore Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

BioMarin Pharmaceutical Inc. - Common Stock

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Notizie